SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- obesity/erectile dysfunction

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: scaram(o)uche11/15/2019 2:24:27 PM
   of 435
 
Cannabis Cannabinoid Res. 2019 Sep 23;4(3):165-176. doi: 10.1089/can.2019.0016. eCollection 2019.

Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of ?9-THC at Human CB1 and CB2 Receptors.

Santiago M1, Sachdev S1, Arnold JC2,3, McGregor IS2,4, Connor M1.

1
Department of Biomedical Sciences, Macquarie University, Sydney, New South Wales, Australia.
2
The Lambert Initiative for Cannabinoid Therapeutics, The University of Sydney, Sydney, New South Wales, Australia.
3
Discipline of Pharmacology, The University of Sydney, Sydney, New South Wales, Australia.
4
School of Psychology, The University of Sydney, Sydney, New South Wales, Australia.

Introduction: Compounds present in Cannabis sativa such as phytocannabinoids and terpenoids may act in concert to elicit therapeutic effects. Cannabinoids such as ?9-tetrahydrocannabinol (?9-THC) directly activate cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2); however, it is not known if terpenoids present in Cannabis also affect cannabinoid receptor signaling. Therefore, we examined six common terpenoids alone, and in combination with cannabinoid receptor agonists, on CB1 and CB2 signaling in vitro. Materials and Methods: Potassium channel activity in AtT20 FlpIn cells transfected with human CB1 or CB2 receptors was measured in real time using FLIPR® membrane potential dye in a FlexStation 3 plate reader. Terpenoids were tested individually and in combination for periods up to 30?min. Endogenous somatostatin receptors served as a control for direct effects of drugs on potassium channels. Results: a-Pinene, ß-pinene, ß-caryophyllene, linalool, limonene, and ß-myrcene (up to 30-100?µM) did not change membrane potential in AtT20 cells expressing CB1 or CB2, or affect the response to a maximally effective concentration of the synthetic cannabinoid CP55,940. The presence of individual or a combination of terpenoids did not affect the hyperpolarization produced by ?9-THC (10?µM): (CB1: control, 59%±7%; with terpenoids (10?µM each) 55%±4%; CB2: ?9-THC 16%±5%, with terpenoids (10?µM each) 17%±4%). To investigate possible effect on desensitization of CB1 responses, all six terpenoids were added together with ?9-THC and signaling measured continuously over 30?min. Terpenoids did not affect desensitization, after 30?min the control hyperpolarization recovered by 63%±6% in the presence of the terpenoids recovery was 61%±5%. Discussion: None of the six of the most common terpenoids in Cannabis directly activated CB1 or CB2, or modulated the signaling of the phytocannabinoid agonist ?9-THC. These results suggest that if a phytocannabinoid-terpenoid entourage effect exists, it is not at the CB1 or CB2 receptor level. It remains possible that terpenoids activate CB1 and CB2 signaling pathways that do not involve potassium channels; however, it seems more likely that they may act at different molecular target(s) in the neuronal circuits important for the behavioral effect of Cannabis.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext